NCT04505046 (INSPiRED-WP3) is a clinical trial in Testing, sponsored by Centre de Recherche Médicale de Lambaréné.

Who is sponsoring NCT04505046?

NCT04505046 is sponsored by Centre de Recherche Médicale de Lambaréné.

What condition does NCT04505046 study?

NCT04505046 studies Testing, Performance, Specificity, Sensitivity.

Is NCT04505046 still recruiting?

NCT04505046 is currently status unknown. Last updated 7 August 2020.

Last reviewed 2020-08-07 · How we verify

NCT04505046: INSPiRED-WP3

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.

Status unknown Last updated 7 August 2020

What this trial tests

trial in Testing in 460 participants. Status unknown.

Timeline

20 March 2020

Primary endpoint
31 December 2022

31 December 2023

Quick facts

Lead sponsor	Centre de Recherche Médicale de Lambaréné
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	460
Start date	20 March 2020
Primary completion	31 December 2022
Estimated completion	31 December 2023
Sites	1 location across Gabon

Conditions studied

Testing — all drugs for Testing →
Performance — all drugs for Performance →
Specificity — all drugs for Specificity →
Sensitivity — all drugs for Sensitivity →

Sponsor

Centre de Recherche Médicale de Lambaréné — full company profile →

Who can join

Adults 2 to 50, any sex, with Testing or Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Malaria, schistosomiasis and ancylostomiasis are three parasitic diseases which affect hundreds of millions of people and are an important cause of global mortality and morbidity. For the control of these poverty related parasitic diseases, and to complement chemotherapeutic strategies, accurate and accessible diagnostic procedures play a crucial role. In recent years, innovative smart mobile technologies have been applied for detection and identification of cultured parasite species, which is basically based on sample imaging and parasite morphology identification. Promising advances have been made with this technology and coupled with its small size, low cost and easy to manipulate, makes it suitable for point of care diagnostics in low resource setting. The aim of the proposed explorative study is to further validate sensitivity and specificity of each of the developed devices, using besides microscopy a range of more advanced reference tests.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A review on innovative optical devices for the diagnosis of human soil-transmitted helminthiasis and schistosomiasis: from research and development to commercialization.
Meulah B, Bengtson M, Lieshout LV, Hokke CH, et al · · 2023 · cited 16× · PMID 36683384 · DOI 10.1017/s0031182022001664
Validation of artificial intelligence-based digital microscopy for automated detection of Schistosoma haematobium eggs in urine in Gabon.
Meulah B, Oyibo P, Hoekstra PT, Moure PAN, et al · · 2024 · cited 12× · PMID 38394298 · DOI 10.1371/journal.pntd.0011967

Verify or expand the search:

Other Centre de Recherche Médicale de Lambaréné trials

Trials by the same sponsor.

NCT07017803 — Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region · not yet recruiting
NCT05905432 — Pan-Malaria Transmission-Blocking Vaccine AnAPN1 · Phase 1 · completed
NCT05929157 — A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate · Phase 1, PHASE2 · unknown
NCT05130398 — Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon · Phase 1, PHASE2 · completed
NCT04847817 — Important Data on COVID-19 Profile in Africa · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04505046 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre de Recherche Médicale de Lambaréné
Last refreshed: 7 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04505046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing